Literature DB >> 7913111

T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA.

D E Elliott1, A Metwali, A M Blum, M Sandor, R Lynch, J V Weinstock.   

Abstract

Schistosomiasis mansoni is a disease characterized by liver and intestinal granulomas. Previous investigations in our laboratory showed that nylon wool-adherent CD4+ T lymphocytes isolated from murine hepatic schistosome granulomas express receptors for somatostatin 1-14. Moreover, somatostatin 1-14 substantially decreased IFN-gamma and IgG2a, but not IL-5 secretion by dispersed granuloma cells. This paper extends these observations by defining the somatostatin receptor (SSTR) isoform most likely expressed by granuloma inflammatory lymphocytes. Amplification of mRNA by reverse transcription PCR shows SSTR1, SSTR2, and SSTR3 mRNA in normal mouse brain and other tissues. Nevertheless, only the SSTR2 PCR product was amplified from granuloma cell RNA. The nucleotide sequence of the granuloma SSTR2 PCR product from inflammatory cells is identical to the CBA murine brain SSTR2 cDNA sequence. Granuloma-derived T cell lines, FACS-isolated granuloma CD4+ T cells, thymocytes, splenocytes, and cloned T cell lines all contain mRNA for SSTR2 by reverse transcription PCR. Moreover, both SSTR2A and the splice variant SSTR2B can be amplified from dispersed granuloma cells, granuloma T cell lines, thymocytes, and splenocytes. This is the first demonstration that inflammatory cells produce mRNA for an authentic somatostatin receptor. It is probable that the lymphocyte SSTR2 receptor mediates somatostatin-induced modulation of IFN-gamma secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913111

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.

Authors:  Prema Robinson; A Clinton White; Dorothy E Lewis; John Thornby; Elliott David; Joel Weinstock
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Effects of somatostatin and octreotide on cytokine and chemokine production by lipopolysaccharide-activated peripheral blood mononuclear cells.

Authors:  F ter Veld; B Rose; R Mussmann; S Martin; C Herder; K Kempf
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

3.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

4.  Somatostatin negatively regulates parasite burden and granulomatous responses in cysticercosis.

Authors:  Mitra Khumbatta; Bahrom Firozgary; David John Tweardy; Joel Weinstock; Gohar Firozgary; Zal Bhatena; Tushar Bulsara; Ricardo Siller; Prema Robinson
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

5.  Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?

Authors:  Petra Zubin Maslov; Navneet Narula; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2019-07-22       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.